The Food and Drugs Authority (FDA) has cautioned the general public about the recall of all batches of Polyfort Suspension in Nigeria.
According to the FDA, the recall is due to negative results from a series of ongoing stability tests.
The said drug is used for the treatment of heartburn, indigestion and hyperacidity and is manufactured in Nigeria by Swiss Pharma Limited.
A statement issued by the Authority on Tuesday, May 9, 2021, said “the FDA’s surveillance team is actively monitoring the country’s ports of entry and markets to ensure that such unregistered products are not available in the country.”
